SAN DIEGO, April 16 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN - News) today reported financial results for the quarter ended March 31, 2007. The Company reported total revenue of $172.0 million for the first quarter, including net product sales of $162.0 million. Net loss for the quarter ended March 31, 2007 was $49.4 million, or $0.38 per share. At March 31, 2007, the Company held cash, cash equivalents and short-term investments of approximately $634.5 million.
